J Comp Neurol 395:535547 Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
NBA star Charles Barkley said he lost over 60 pounds in six months after taking Ozempic competitor Mounjaro, also known as tirzepatide, while eating healthily and exercising
HCC / Risk Adjustment (v28) Obesity has significant risk adjustment implications under the CMS-HCC Model v28 used for Medicare Advantage plan payments (fully implemented 20242026 blend)
Clinical Child and Family Psychology Review, 18 (1), 5076
Its a sensory, emotional and behavioral reset, and brands that understand that nuance could score loyalty long after the GLP-1 craze moves from headlines to habit
According to The Guardian, researchers in Europe have developed an AI tool called Delphi-2M that can predict a person's risk for more than 1,000 diseases